On April 5, 2019 NexImmune, an emerging leader in the field of antigen-directed immunotherapy, reported that Scott Carmer, Neximmune’s Chief Executive Officer, will be participating and presenting a corporate update at the following conferences (Press release, NexImmune, APR 5, 2019, View Source [SID1234554954]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies Immuno-Oncology Cell Therapy Summit
Friday, April 5th, 3:05PM ET
Boston, MA

Solebury Trout Private Company Showcase
Thursday, April 18th, 10:50AM ET
Boston, MA